These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24561192)

  • 21. Knock-down of USP22 by small interfering RNA interference inhibits HepG2 cell proliferation and induces cell cycle arrest.
    Ling SB; Sun DG; Tang B; Guo C; Zhang Y; Liang R; Wang LM
    Cell Mol Biol (Noisy-le-grand); 2012 Dec; 58 Suppl():OL1803-8. PubMed ID: 23217440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted eradication of gastric cancer stem cells by CD44 targeting USP22 small interfering RNA-loaded nanoliposomes.
    Yang F; Zheng Z; Xue X; Zheng L; Qin J; Li H; Zhou Y; Fang G
    Future Oncol; 2019 Jan; 15(3):281-295. PubMed ID: 30543303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NFATc2 mediates epigenetic modification of dendritic cell cytokine and chemokine responses to dectin-1 stimulation.
    Yu HB; Yurieva M; Balachander A; Foo I; Leong X; Zelante T; Zolezzi F; Poidinger M; Ricciardi-Castagnoli P
    Nucleic Acids Res; 2015 Jan; 43(2):836-47. PubMed ID: 25550437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cot/Tpl2 and PKCzeta cooperate in the regulation of the transcriptional activity of NFATc2 through the phosphorylation of its amino-terminal domain.
    Gómez-Casero E; San-Antonio B; Iñiguez MA; Fresno M
    Cell Signal; 2007 Aug; 19(8):1652-61. PubMed ID: 17398070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential contribution of NFATc2 and NFATc1 to TNF-alpha gene expression in T cells.
    Kaminuma O; Kitamura F; Kitamura N; Hiroi T; Miyoshi H; Miyawaki A; Miyatake S
    J Immunol; 2008 Jan; 180(1):319-26. PubMed ID: 18097033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma.
    Yun X; Zhang K; Wang J; Pangeni RP; Yang L; Bonner M; Wu J; Wang J; Nardi IK; Gao M; Raz DJ
    Mol Cancer Res; 2018 Jul; 16(7):1161-1171. PubMed ID: 29720480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
    Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
    Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.
    Guo J; Zhao J; Fu W; Xu Q; Huang D
    Front Immunol; 2022; 13():918314. PubMed ID: 35935969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53.
    Ding W; Tong Y; Zhang X; Pan M; Chen S
    Sci Rep; 2016 Jan; 6():19793. PubMed ID: 26795951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells.
    Lv L; Xiao XY; Gu ZH; Zeng FQ; Huang LQ; Jiang GS
    Mol Cell Biochem; 2011 Jan; 346(1-2):11-21. PubMed ID: 20824490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex.
    Armour SM; Bennett EJ; Braun CR; Zhang XY; McMahon SB; Gygi SP; Harper JW; Sinclair DA
    Mol Cell Biol; 2013 Apr; 33(8):1487-502. PubMed ID: 23382074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The deubiquitinating enzyme activity of USP22 is necessary for regulating HeLa cell growth.
    Liu YL; Zheng J; Tang LJ; Han W; Wang JM; Liu DW; Tian QB
    Gene; 2015 Nov; 572(1):49-56. PubMed ID: 26143114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Construction and identification of eukaryotic expression plasmid expressing siRNA targeting USP22 gene].
    Xiong JJ; Gan LJ; Lin L; Gong Z; Wu ZH; Li WD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):166-9. PubMed ID: 21500546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between NFATc2 and the transcription factor Sp1 in pancreatic carcinoma cells PaTu 8988t.
    Malsy M; Graf B; Almstedt K
    BMC Mol Biol; 2017 Aug; 18(1):20. PubMed ID: 28774282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
    Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
    Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
    Liu YL; Yang YM; Xu H; Dong XS
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High mobility group box-1 protein acts as a coactivator of nuclear factor of activated T cells-2 in promoting interleukin-2 transcription.
    Liu H; Yao YM; Ding LH; Zhang H; Yuan B; Song Q; Ye QN; Huang CF; Sheng ZY
    Int J Biochem Cell Biol; 2009 Mar; 41(3):641-8. PubMed ID: 18707018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu J; Yang D; Zhang H; Liu W; Zhao Y; Lu H; Meng Q; Pang H; Chen X; Liu Y; Cai L
    Lung Cancer; 2015 Jun; 88(3):239-45. PubMed ID: 25907317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ubiquitin specific peptidase 22 regulates the transcription activity of mitogen-activated protein kinase kinase 6 gene].
    Liu J; Xie X; Wu P; Xiong J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 44(2):122-127. PubMed ID: 30837379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression.
    Zhang XY; Varthi M; Sykes SM; Phillips C; Warzecha C; Zhu W; Wyce A; Thorne AW; Berger SL; McMahon SB
    Mol Cell; 2008 Jan; 29(1):102-11. PubMed ID: 18206973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.